ZEVALIN 1,6 MG/ML TROUS FL 4
(Ibritumomab - Tiuxetan) - Maladie rare sans désignation orpheline
*Consolidation therapy after remission induction in previously untreated patients with follicular lymphoma.
*Treatment of adult patients with rituximab relapsed or refractory CD20+ follicular B-cell non-Hodgkin’s lymphoma (NHL).